A股最大干细胞概念股中源协和从年初至今股价飞涨,但眼前并无业绩支撑,实际控制人李德福如何应对外界质疑?北京,平日少见的晴空。一个四合院改造的茶社,微风将树上的碎枝叶扫到了茶杯里,李德福看了微微一笑,这里环境不太好。“有些事情历史因缘太复杂了,我不想沉渣泛起。”针对记者的提问,这位永泰红磡集团董事长、中源协和(SH600645)实际控制人呷完一口浓茶,反问:“我在资 A shares of the concept of the largest source of stem cells shares in the source so far from the stock price soaring, but there is no immediate performance support, the actual controller Li Defu how to deal with the outside world questioned? Beijing, Weekday rare clear sky. A tea house transformed by a courtyard, the breeze swept the branches and leaves of trees to the cup, Li Defu saw a slight smile, where the environment is not very good. ”In response to a reporter’s question, the chairman of Yongtai Hung Hom Group and the actual controller of Zhongyue Xiehe (SH600645) finished a strong tea and asked: " I am funding